Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

1. Pfizer’s Q3 earnings expected at 64 cents per share, down from $1.06. 2. Estimated revenue for the quarter is $16.52 billion, down from $17.7 billion. 3. Pfizer filed a lawsuit against Metsera and Novor Nordisk for breach of contract. 4. Recent analyst ratings lead to mixed outlook on stock price targets. 5. PFE shares slightly rose to $24.66 prior to earnings release.